HYALURONATE VISCOSUPPLEMENTATION FOR TRAPEZIOMETACARPAL OSTEOARTHRITIS

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We propose that intraarticular injection of EUFLEXXA¿ into the basal joint (trapeziometacarpal joint of the thumb) will provide significant pain relief and restoration of function as compared to placebo (normal saline) for osteoarthritis of the basal joint. EUFLEXXA is 1% sodium hyaluronate and is FDA approved and in clinical use for the treatment of knee joint osteoarthritis.